Stay up-to-date with the latest news and information from the drug testing industry by subscribing to Results, our monthly newsletter.
Your Privacy Choices | Privacy Notices | Privacy Shield | Terms | Language Assistance / Non-Discrimination Notice | Asistencia de Idiomas / Aviso de no Discriminación | 語言協助 / 不䈚視通知
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks — ® and ™ — are the property of their respective owners. © 2000-2024 Quest Diagnostics Incorporated. All rights reserved.
Quest Diagnostics Employer Solutions announced today that our Lenexa, Kansas drug testing laboratory will begin screening and confirming urine drug testing samples for the presence of cotinine, a metabolite of nicotine which is indicative of tobacco use.
Cotinine testing is something that we’ve historically performed in our drug testing laboratories in California and Pennsylvania, and by introducing this testing capability into our Kansas laboratory, our clients in the Midwestern portions of the country should experience improved turnaround times for their results on account of logistical efficiencies.
For more information about drug testing, visit our website.